Association of a common genetic variant with Parkinson’s disease is mediated by microglia is a research paper published in Science Translational Medicine (2022). On theSindex it has a DataRank of 0.688. It has been cited 97 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.688
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Intramural NIH HHS
Grant: ZIA AG000947
Intramural NIH HHS
Grant: Z01 AG000949
Intramural NIH HHS
Grant: ZIA NS003154
NIA NIH HHS
Grant: P30 AG072946
NIA NIH HHS
Grant: K01 AG000947
Intramural NIH HHS
Grant: Z01 ES101986
Intramural NIH HHS
Grant: Z99 AG999999
National Institutes of Health
Grant: 1ZIAAG000947-08
Gene expression in the human brain
National Institutes of Health
Grant: 1ZIANS003154-09
Genetic characterization of atypical parkinsonism
National Institutes of Health
Grant: 3P30AG072946-02S1
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
National Institutes of Health
Grant: 1Z01AG000949-01
Genome wide SNP analysis in Neurological disorders
National Institutes of Health
Grant: 1Z01ES101986-03
Prospective studies on Parkinson's disease
FWCI
12.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
Additional file 2 of Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
Additional file 3 of Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
Additional file 3 of Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
Additional file 1 of Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
Additional file 1 of Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
Additional file 11 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 10 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 6 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 2 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 9 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 5 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 11 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 3 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 6 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 10 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 12 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 4 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 3 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease
Additional file 8 of Transcriptomic changes in oligodendrocytes and precursor cells associate with clinical outcomes of Parkinson’s disease